Mission
CANCER RESEARCH AND TREATMENT FUND,INC.(CR&T) FUNDS RESEARCH EMPHASIZING THE CAUSE,PREVENTION,TREATMENT,AND CURE OF MYELOPROLIFERATIVE NEOPLASMS(MPNs)AND ALSOFUNDS OTHER BLOOD AND SOLID TUMOR CANCER RESEARCH.
CANCER RESEARCH AND TREATMENT FUND INC is a Public Charity headquartered in NEW YORK, NY. Financial data from the 2025 filing: $880K revenue, $1.1M expenses, $16.7M total assets. 32 publicly reported grants to this organization, totaling roughly $438K, appear in IRS filings.
CANCER RESEARCH AND TREATMENT FUND,INC.(CR&T) FUNDS RESEARCH EMPHASIZING THE CAUSE,PREVENTION,TREATMENT,AND CURE OF MYELOPROLIFERATIVE NEOPLASMS(MPNs)AND ALSOFUNDS OTHER BLOOD AND SOLID TUMOR CANCER RESEARCH.
How Cancer Research and Treatment Fund Inc divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Showing up to 5 of 32 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $880K | $1.1M | $16.7M |
| 2024 | $1.1M | $1.0M | $15.2M |
| 2023 | $1.0M | $1.0M | $13.7M |
| 2022 | $573K | $957K | $12.6M |
| 2021 | $1.1M | $811K | $14.9M |
Between 2021 and 2025, reported annual revenue declined from $1.1M to $880K (-20%), with total assets most recently reported at $16.7M.
Interactive year-over-year charts and full filing details available with membership.